This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Influence of Vitamin D on Inflammatory Bowel Disease Remission

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2010 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
Technion, Israel Institute of Technology
Information provided by:
Hillel Yaffe Medical Center Identifier:
First received: May 10, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
Vitamin D has been shown to influence a multitude of systems. We intend to see whether different types of Vitamin D supplements have an effect on inflammatory bowel disease.

Condition Intervention
Inflammatory Bowel Disease Dietary Supplement: Vitamin D Other: Water or milk Dietary Supplement: Vitamin D enriched milk

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Inflammatory disease remission [ Time Frame: One year ]

Estimated Enrollment: 90
Study Start Date: June 2010
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Vitamin D Dietary Supplement: Vitamin D
Placebo Comparator: Placebo Other: Water or milk
Active Comparator: Unique vehicle for Vitamin D supplementation Dietary Supplement: Vitamin D enriched milk


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Mild to moderate inflammatory bowel disease

Exclusion Criteria:

  • Hypersensitivity to milk products
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01121796

Contact: Zvi Fireman, MD
Contact: Oren Atia, MD

Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
Technion, Israel Institute of Technology
  More Information

Responsible Party: Dr. Zvi Fireman, Director Gastroenterology Institute, Hillel Yaffe Medical Center Identifier: NCT01121796     History of Changes
Other Study ID Numbers: HY100510
Study First Received: May 10, 2010
Last Updated: May 10, 2010

Additional relevant MeSH terms:
Intestinal Diseases
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Vitamin D
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents processed this record on June 22, 2017